PT1293198E - Dispositivo de administracao transdermica para o tratamento de patologias do tracto urinario - Google Patents

Dispositivo de administracao transdermica para o tratamento de patologias do tracto urinario

Info

Publication number
PT1293198E
PT1293198E PT01121687T PT01121687T PT1293198E PT 1293198 E PT1293198 E PT 1293198E PT 01121687 T PT01121687 T PT 01121687T PT 01121687 T PT01121687 T PT 01121687T PT 1293198 E PT1293198 E PT 1293198E
Authority
PT
Portugal
Prior art keywords
group
substituted
alkyl
phenyl
halogen atoms
Prior art date
Application number
PT01121687T
Other languages
English (en)
Inventor
Hans-Michael Wolff
Frank Dr Dressen
Schacht Dietrich
Original Assignee
Kissei Pharmaceutical Co Lda
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Lda, Sanol Arznei Schwarz Gmbh filed Critical Kissei Pharmaceutical Co Lda
Publication of PT1293198E publication Critical patent/PT1293198E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
PT01121687T 2001-09-14 2001-09-14 Dispositivo de administracao transdermica para o tratamento de patologias do tracto urinario PT1293198E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01121687A EP1293198B1 (en) 2001-09-14 2001-09-14 Device for transdermal administration for the treatment of urinary tract disorders

Publications (1)

Publication Number Publication Date
PT1293198E true PT1293198E (pt) 2005-06-30

Family

ID=8178599

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01121687T PT1293198E (pt) 2001-09-14 2001-09-14 Dispositivo de administracao transdermica para o tratamento de patologias do tracto urinario

Country Status (9)

Country Link
US (1) US20050226919A1 (pt)
EP (1) EP1293198B1 (pt)
AT (1) ATE288745T1 (pt)
DE (1) DE60108870T2 (pt)
DK (1) DK1293198T3 (pt)
ES (1) ES2237515T3 (pt)
HK (1) HK1054327B (pt)
PT (1) PT1293198E (pt)
WO (1) WO2003024432A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE535242T1 (de) * 2004-10-06 2011-12-15 Kissei Pharmaceutical Medizinische zusammensetzung zur prävention des übergangs zu einer operativen behandlung bei prostatahypertrophie
ATE415153T1 (de) * 2005-06-06 2008-12-15 Nitto Denko Corp Pharmazeutische zusammensetzung zur perkutane absorption unter verwendung von einem metalchlorid, vorzugsweise natriumchlorid, zur vorbeugung von kohäsionsschwäche
WO2012057212A1 (ja) * 2010-10-28 2012-05-03 久光製薬株式会社 経皮吸収型製剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518113A1 (de) * 1991-06-10 1992-12-16 Schwarz Pharma Ag Nitroglycerin-Pflaster und Verfahren zu seiner Herstellung
DE122010000031I1 (de) * 1992-12-02 2010-10-21 Kissei Pharmaceutical Indolin Verbindungen zur Behandlung von Dysurien
IL120302A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
IL120303A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
WO1999048530A1 (en) * 1998-03-23 1999-09-30 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
US6541669B1 (en) * 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists

Also Published As

Publication number Publication date
DK1293198T3 (da) 2005-06-06
WO2003024432A2 (en) 2003-03-27
ATE288745T1 (de) 2005-02-15
HK1054327B (zh) 2005-07-29
ES2237515T3 (es) 2005-08-01
HK1054327A1 (en) 2003-11-28
DE60108870T2 (de) 2005-07-28
US20050226919A1 (en) 2005-10-13
EP1293198A1 (en) 2003-03-19
EP1293198B1 (en) 2005-02-09
DE60108870D1 (de) 2005-03-17
WO2003024432A3 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
AP9801302A0 (en) Indole compounds as anti-inflammatory/analgesic agents..
DK1780197T3 (da) 5-Substituerede 2-phenylamino-benzamider som MEK-inhibitorer
BR0013949A (pt) Prodroga de taxano, composição farmacêutica, e, método de tratamento de um paciente mamìfero
DE60222596D1 (de) Fettsäureverbindungen und deren herstellung und verwendungen
NL300175I2 (nl) Methylsulfonylfenyl-2-(5H)-furanonen als remmers van COX-2.
SE0301446D0 (sv) New Compounds
FI954243A0 (fi) Farmaseuttiset yhdisteet
PT1251846E (pt) Taxanos com carbonato c-4
DE60102171D1 (de) Ketolidantibiotika
PT1293198E (pt) Dispositivo de administracao transdermica para o tratamento de patologias do tracto urinario
DE60205338D1 (de) Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten
EA200300940A1 (ru) Энтеральные соли кетокислот и аминокислот
DK1156058T3 (da) Fremgangsmåde til fremstilling af (E,Z) 3-(2-aminoethoxyimino)-androstan-6,17-dion og analoger deraf
ATE535242T1 (de) Medizinische zusammensetzung zur prävention des übergangs zu einer operativen behandlung bei prostatahypertrophie
DK1205476T3 (da) Fremgangsmåde til syntese af N-(mercaptoacyl)-aminosyrederivater ud fra alfa-substituerede acrylsyrer
DE60110233D1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
ATE511395T1 (de) Mittel zur behandlung von glomerulopathie
ATE278667T1 (de) Tetramsäure-derivate zur verwendung in medizin und lebensmitteltechnologie
ATE278701T1 (de) Malto-oligosaccharide und deren verwendung
RU2008114394A (ru) Лечение стрессового недержания мочи и смешанного недержания мочи
ATE225785T1 (de) Tetrazolylalkyl-indolderivate als entzündungshemmende und analgetische mittel
EA199900570A1 (ru) Гипоталамо-гипофизарное средство, вызывающее устойчивую стадию торможения и/или покоя у собак и стадию покоя у кошек (анэструс)